![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Clinical Benefits, Economic Savings and Faster Time to HCV Elimination with a Simplified
8-Week Treatment and Monitoring Program in Chronic F0-F3 Naïve Patients in the US
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Jordan Feld1, Yuri Sanchez Gonzalez2, Ana Pires Dos Santos2, Olivier Ethgen3,4
1Toronto Centre for Liver Disease, Toronto, Canada; 2AbbVie Inc., North Chicago, Illinois, United States; 3SERFAN Innovation, Namur, Belgium; 4University of Liège, Liège, Belgium
![disussion](../images%20/112819/112819-4/disussion.gif)
![1128182](../images%20/112819/112819-4/1128182.gif)
![1128183](../images%20/112819/112819-4/1128183.gif)
![1128184](../images%20/112819/112819-4/1128184.gif)
![1128185](../images%20/112819/112819-4/1128185.gif)
![1128186](../images%20/112819/112819-4/1128186.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|